Securities Star News, Guotou Fengle (000713) responded to investor questions on the investor relations platform on February 26.
Investor: Your company stated in May 2025 that it has completed the genetic trait transfer for Fengle 520LP, Tongyu 609D, Fengle 732D, Tongyu 105LP, Lile 969D, and TK601BF, and all have entered the variety approval stage. What is the progress? Are there any other varieties that have completed genetic trait transfer and entered the approval stage?
Guotou Fengle Secretary: Thank you for your attention. Currently, our main corn varieties, such as Fengle 520LP and Tongyu 609D, have undergone genetic trait transfer. The approval of these varieties and the specific approval timeline are uncertain. Please be aware of investment risks.
The above content is compiled from publicly available information by Securities Star and generated by AI algorithm (Network Information Calculation Backup 310104345710301240019), and does not constitute investment advice.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Guotou Fengle: The company is currently conducting genetic trait transfer work on the main corn varieties.
Securities Star News, Guotou Fengle (000713) responded to investor questions on the investor relations platform on February 26.
Investor: Your company stated in May 2025 that it has completed the genetic trait transfer for Fengle 520LP, Tongyu 609D, Fengle 732D, Tongyu 105LP, Lile 969D, and TK601BF, and all have entered the variety approval stage. What is the progress? Are there any other varieties that have completed genetic trait transfer and entered the approval stage?
Guotou Fengle Secretary: Thank you for your attention. Currently, our main corn varieties, such as Fengle 520LP and Tongyu 609D, have undergone genetic trait transfer. The approval of these varieties and the specific approval timeline are uncertain. Please be aware of investment risks.
The above content is compiled from publicly available information by Securities Star and generated by AI algorithm (Network Information Calculation Backup 310104345710301240019), and does not constitute investment advice.